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Protein modification by SUMO affects a wide range
of protein substrates. Surprisingly, although SUMO
pathway mutants display strong phenotypes, the
function of individual SUMO modifications is often
enigmatic, and SUMOylation-defective mutants
commonly lack notable phenotypes. Here, we use
DNA double-strand break repair as an example and
show that DNA damage triggers a SUMOylation
wave, leading to simultaneous multisite modifica-
tions of several repair proteins of the same pathway.
Catalyzed by a DNA-bound SUMO ligase and trig-
gered by single-stranded DNA, SUMOylation stabi-
lizes physical interactions between the proteins.
Notably, only wholesale elimination of SUMOylation
of several repair proteins significantly affects the
homologous recombination pathway by consider-
ably slowing down DNA repair. Thus, SUMO acts
synergistically on several proteins, and individual
modifications only add up to efficient repair. We
propose that SUMOylation may thus often target
a protein group rather than individual proteins,
whereas localized modification enzymes and highly
specific triggers ensure specificity.INTRODUCTION
Posttranslational modifications (PTMs) greatly expand the
range of functions of proteins. The majority of such modifica-
tions are attached functional groups (like phosphate, acetate,
or lipids), which change the activities or localization of proteins
or induce structural alterations. Moreover, because PTMs are
usually reversible and thus have switch-like properties, they
are instrumental for the regulation and directionality of cellular
pathways and signaling cascades. PTMs typically target indi-
vidual proteins, and thus, PTM enzymes usually act highly
selectively.
A special PTMclass is proteinmodification by covalent attach-
ment of proteins of the ubiquitin family. For ubiquitylation, the
principles of substrate selectivity and the mechanistic conse-quences of the modification are well understood (Kerscher
et al., 2006). High specificity toward individual substrates is
achieved by a great diversity of ubiquitin ligases and numerous
deconjugation enzymes. In the case of ubiquitin’s proteolytic
role, the ubiquitin modification (usually in the form of a lysine
(K)-48 or K6 and K29 polyubiquitin chain) is recognized by dedi-
cated ubiquitin receptors, which escort the polyubiquitylated
protein to the proteasome (Finley, 2009; Richly et al., 2005). In
cases when ubiquitin does not function as a proteolytic tag
(e.g., monoubiquitin; K63-linked polyubiquitin chain), the modi-
fied proteins are recognized by different kinds of ubiquitin
receptors (e.g., receptors engaged in protein sorting) or binding
partners that possess ubiquitin-binding domains. Notably,
numerous ubiquitin-binding domains exist, some of which
exhibit specificity for certain types of polyubiquitin linkages or
even the length of the polyubiquitin chain.
Much less is known regarding howmodification by the ubiqui-
tin-related protein SUMO affects the function of substrates and
how specificity is provided. Surprisingly, even though SUMOyla-
tion targets a large number of cellular proteins as well, its enzy-
matic machinery, both for conjugation and deconjugation, is
much more simply organized compared to the elaborate ubiqui-
tin pathway (Geiss-Friedlander and Melchior, 2007). In fact, only
a handful of enzymes have been identified that mediate SUMOy-
lation and de-SUMOylation, and their specificity in vitro seems
rather promiscuous. Likewise, the recognition of the SUMO
modification is surprisingly simple, as only two SUMO-binding
motifs, a short hydrophobic sequence known as SUMO-interact-
ing motif (SIM) and a specific zinc finger (ZZ zinc finger), have
been identified (Danielsen et al., 2012; Song et al., 2004).
Some additional selectivity may come from substrate or SIM
modification by other PTMs (Stehmeier and Muller, 2009; Ull-
mann et al., 2012), but overall, the question of specificity in the
SUMO pathway remains largely unexplained.
SUMO is essential for viability for most eukaryotes, and
consequently, mutants defective in components of the SUMO
pathway are either lethal or have strong pleiotropic phenotypes
(Geiss-Friedlander and Melchior, 2007). Judging from these
phenotypes, SUMO plays numerous cellular roles, ranging
from signal transduction to DNA transactions, e.g., DNA repair.
Indeed, the majority of known SUMO substrates are nuclear
proteins, but the significance of the SUMO modification is
known for a few substrates only. SUMOylation of the DNA exci-
sion repair enzyme thymine-DNA glycosylase (TDG) is a rareCell 151, 807–820, November 9, 2012 ª2012 Elsevier Inc. 807
example of a conformational change induced by the SUMO
modification (Steinacher and Scha¨r, 2005). This enzymatically
important structural alteration is achieved through an intramo-
lecular interaction of conjugated SUMO with a SIM of TDG.
Another well-understood example is SUMOylation of prolifer-
ating cell nuclear antigen (PCNA) (Hoege et al., 2002; Papouli
et al., 2005; Pfander et al., 2005). In this case, SUMOylation
recruits Srs2, a recombination-inhibiting enzyme, which re-
moves the recombinase Rad51 from chromatin. For PCNA inter-
action, Srs2 possesses a PIP (PCNA-interacting protein) box,
but crucial additional affinity for SUMOylated PCNA is provided
by a SIM, located near the PIP box in Srs2’s carboxyl
(C)-terminal tail (Armstrong et al., 2012; Pfander et al., 2005).
However, PCNA SUMOylation might be a special case as the
same residue in PCNA (K164) is also alternatively targeted by
mono- and K63-linked polyubiquitylation for other repair func-
tions (Hoege et al., 2002). Another singular case is SUMOylation
of RanGAP of higher eukaryotes as this protein is not only
a substrate but is also part of multisubunit SUMO ligase (Werner
et al., 2012).
For the vast majority of currently identified SUMO substrates,
the biological significance and themechanistic consequences of
SUMOylation are not known. Surprisingly, in the few cases in
which the SUMOylation acceptor lysine residues had been iden-
tified, the respective mutants (lysine to arginine replacements;
KR) often barely exhibit deleterious phenotypes (Sacher et al.,
2006; Silver et al., 2011). In fact, this paradoxical discrepancy
between strong phenotypes of SUMO pathway mutants and
the scarceness of phenotypes of mutants deficient in specific
SUMO modifications seems characteristic for the SUMO
pathway. Because of this feature, one could even argue that
several in vivo SUMOylation events are ‘‘silent’’ modifications
caused by a promiscuous specificity of a simple organized enzy-
matic pathway.
Here, rather than by analyzing phenotypes of SUMO pathway
mutants, we address SUMOylation specificity and function at the
substrate level. We focused on DNA double-strand break (DSB)
repair by homologous recombination (HR) as this pathway is well
characterized and shows strong ties to the SUMO system (Alt-
mannova et al., 2010; Branzei et al., 2006; Cremona et al.,
2012; Dou et al., 2011; Galanty et al., 2009; Maeda et al., 2004;
Morris et al., 2009; Ohuchi et al., 2008; Sacher et al., 2006;
Torres-Rosell et al., 2007). SUMO pathway mutants exhibit
robust sensitivities toward reagents that generate DSBs in vivo,
and several HR proteins are known to be SUMOylated. Nonethe-
less, in the rare cases in which the SUMO acceptor sites have
been studied, the corresponding mutants exhibit only very mild
phenotypes and mainly only when the demand for HR is very
high (Ohuchi et al., 2008; Sacher et al., 2006). Prompted by
this finding and because the greater part of HR proteins is
SUMO modified, we speculated that perhaps the SUMOylated
proteins act in concert. Indeed, we found that SUMOylation
targets a protein group rather than a specific protein and found
that individual modifications act synergistically. We finally
discuss amodel in which regulated and highly spatially restricted
SUMOylation provides glue-like properties to nearby substrates
in order to foster their physical interactions and to stabilize
cellular protein complexes.808 Cell 151, 807–820, November 9, 2012 ª2012 Elsevier Inc.RESULTS
A Synchronous DNA Damage-Triggered SUMOylation
Wave Targets a Whole Set of HR Proteins
To address the enigma of specificity in the SUMO pathway, we
selected SUMOylation of HR proteins as a model for our study.
DSB repair is initiated by the heterotrimeric MRX complex
(Mre11, Rad50, and Xrs2), which recognizes and stabilizes the
broken chromosome ends (Lisby et al., 2004). These ends are
prepared for DSB repair via HR by nuclease-mediated single-
stranded DNA (ssDNA) formation (resection), followed by its
rapid coating with the heterotrimeric RPA complex (Rfa1, Rfa2,
and Rfa3). Subsequently, RPA is removed from ssDNA and re-
placed by the recombinase Rad51 with the help of Rad52 and
Rad59. The formed Rad51 nucleoprotein filament is then
engaged in homology search, followed by strand annealing
and final repair (Lisby et al., 2004).
Previous work has shown that the greater part of HR proteins is
modifiedbySUMO (Cremona et al., 2012; Dou et al., 2010; Sacher
et al., 2006). We first aimed to complement these findings by
screening for SUMO conjugates that accumulated upon DNA
damage. We treated cells with the DNA-alkylating agent methyl
methanesulfonate (MMS), which primarily causes replication stall-
ing and DSBs, and compared the level of SUMO-conjugates from
MMS-treated and untreated cells by using a SILAC-based mass
spectrometry protocol (Mann, 2006) (Figure 1A, left). This screen
identified 844 different potential SUMO conjugates; the abun-
dance of most of them did not change upon DNA damage. Strik-
ingly, among those that were strongly enriched in the sample
derived fromMMS-treatedcellswerespecificallyHRproteins (Fig-
ure 1A, right). When we studied these proteins individually, we
noticed that, in practically all cases, SUMOylation yieldedmultiple
species, suggesting that the proteins are perhapsSUMOmodified
at multiple sites (Figures S1A–S1C available online). Neither the
mass spectrometric approach nor a direct analysis identified
SUMOylation of Rad51, indicating that the filament-forming re-
combinase is not a SUMO target. Notably, SUMOylation of the
HR proteins occurred predominantly after exposure to MMS
(Figures S1A–S1C). MMS-induced SUMOylation was also found
for the checkpoint proteins Rad9 and Mrc1 and checkpoint
kinases Mec1 and Tel1 (yeast homologs of mammalian ATR and
ATM) (Figures S1D–S1G). However, their SUMOylation was
already considerable in the absence of MMS, suggesting that
perhaps endogenous DNA damage (e.g., caused by replication
errors) is already sufficient to trigger their SUMOylation.
The observed activity of theSUMOsystem to target awhole set
of HR factors seems surprising given that PTMs typically target
individual proteins to alter their functions. We thus wondered
whether this behavior might be special for HR factors or perhaps
typical for many SUMOylation events. Evidence for the latter
assumption comes from findings that numerous proteins of the
ribosome (Finkbeiner et al., 2011a, 2011b; Panse et al., 2006),
several septins (Johnson and Blobel, 1999; Johnson and Gupta,
2001; Takahashi etal., 2001), andmanyproteins involved innucle-
otideexcision repair (NER) (Silver et al., 2011) areSUMOmodified.
Indeed, when we repeated the SILAC approach mentioned
above, but this time after exposure to UV light, which creates
bulky DNA lesions, we found that proteins specifically involved
Figure 1. Proteins Acting in the Same DNA
Repair Pathway Are Collectively SUMOy-
lated upon a Specific Stimulus
(A) Outline of SILAC experiment performed to
detect SUMOylated substrates enriched after
MMS-induced DNA damage (left). SILAC ratios
(MMS treated versus untreated) for 844 quantified
proteins plotted against the sum of the relevant
peptide intensities (right). Proteins are colored
according to values of MaxQuant Significance(B)
(gray, Significance(B) > 102; black, SUMOylated
proteins enriched after DNA damage with Sig-
nificance(B) % 102; red, proteins with Sig-
nificance(B) < 104 that are involved in HR and
checkpoint activation).
(B) FollowingUV light treatment, specifically factors
implicated in nucleotide excision repair (NER)
become increasingly SUMOylated. Same as in (A),
but cells grown in heavy media were UV irradiated
(80 J/m2) instead of MMS treatment. SILAC ratios
(UV treated versus untreated) for 717 quantified
proteins plotted against the sum of the relevant
peptide intensities. Proteins are colored according
to values of MaxQuant Significance(B) (gray, Sig-
nificance(B) > 107; black, SUMOylated proteins
enriched after UV irradiationwith Significance(B)%
107; red, proteinswith Significance(B)% 108 that
are involved inNER [both transcription-coupledand
global genome repair] and base-excision repair).
See also Figure S1.in NER become increasingly SUMO modified (Figure 1B). This
suggests that proteins actingwithin the same pathway are indeed
often collectively SUMO modified upon a specific stimulus.
Because the HR proteins act together functionally and physi-
cally, we speculated that themodificationsmay serve a common
purpose and are perhaps synchronously triggered. In fact, we
found that theMMSdose dependency of SUMOylation induction
was very similar for all HR proteins analyzed and coincided with
the activation of checkpoint signaling (Figure S2A). Likewise, the
kinetics of SUMOylation after MMS treatment was nearly iden-
tical for the proteins, suggesting a synchronous burst of SUMOy-
lation, which happens seemingly in parallel to the checkpoint
activation wave (Figure S2B). Notably, in mutant strains deficient
in single HR proteins (Drad51 or Drad52), SUMOylation of other
HR proteins still occurred (Figure S2C). This suggests that the
DNA damage-induced synchronous SUMOylation wave targetsCell 151, 807–820,HR proteins collectively. Moreover,
steady-state SUMOylation of RPA even
increased in cells deficient in the down-
stream-acting factors Rad52 and Rad51,
most likely because RPA remains associ-
ated with damaged DNA as the pathway
is blocked.
Extended ssDNA Acts as
SUMOylation Wave Trigger
We next asked how the SUMOylation
wave is induced and what the primarytrigger is. In cycling cells, SUMOylation of the HR proteins was
strongly induced not only by MMS but also by the DSB-inducing
agent Zeocin (Figure S2D). However, exposure to UV light and
4-nitroquinoline 1-oxide (4NQO), which both cause direct DNA
damage, and treatment with the replication inhibitor hydroxyurea
(HU) induced SUMOylation only moderately (Figure S2D). This
suggests that, in particular, reagents that primarily cause DSBs
are potent triggers.
We previously noticed that efficient DNA damage-induced
SUMOylation of Rad52 requires the MRX complex (Sacher
et al., 2006). Indeed, individual deletions of all three genes en-
coding MRX subunits strongly reduced SUMOylation of other
HR proteins as well (Figure 2A). However, because SUMOylation
still weakly occurred, MRX potentiates the induction but does
not seem to be the primary trigger.MRX acts early in the pathway
and is connected to the formation of ssDNA at the DSB byNovember 9, 2012 ª2012 Elsevier Inc. 809
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Figure 2. DNA Resection and Exposure of ssDNA Triggers SUMOylation of DSB Repair Proteins
(A) Disruption of MRX complex by deleting individual subunits results in pronounced decrease of SUMOylation of HR proteins following DNA damage. Denaturing
Ni-NTA pull-down (Ni PD) was performed to isolate HisSUMO conjugates from MMS (0.2%) -treated cells lacking Rad50, Mre11, or Xrs2.
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resection (Mimitou and Symington, 2011). This reaction is usually
initiated by the formation of short 30 ssDNA overhangs created
by the Mre11 subunit of MRX in collaboration with the nuclease
Sae2. After this resection-stimulating (but not essential) first
step, long tracts of ssDNA are formed by the nuclease Exo1
and also by a parallel pathway involving the Sgs1 helicase acting
along with the nuclease Dna2 (Mimitou and Symington, 2008;
Zhu et al., 2008). Interestingly, in the absence of Sae2 (and
also in cells additionally defective in the nuclease activity of the
MRX subunit Mre11 [mre11-H125NDsae2]), HR protein SUMOy-
lation was barely affected (Figures 2B and 2C). In contrast, in
cells deficient in the Exo1 protein (Figure 2B; Dexo1) or its
nuclease activity (Figure 2D; exo1-ND) and also in cells lacking
Sgs1 (Figure 2B), HR protein SUMOylation was strongly
reduced. Indeed, only in the absence of both long-range resec-
tion pathways (Dexo1 and Dsgs1), SUMOylation of the HR
proteins was virtually absent (Figure 2B). Exo1 deficiency or
absence of its activity also strongly diminished the SUMOylation
wave in G1 cells (Figures 2E, 2F, and S2F), emphasizing the
importance of long-range resection for the trigger.
To exclude the possibility that perhaps the process of resec-
tion or the formation of DSBs, rather than extended ssDNA, is
the primary SUMOylation trigger, we induced ssDNA accumula-
tion by other means that do not rely on DSB formation. First, we
exposed G1-arrested cells to UV light (Figure 2F), which creates
extended ssDNA gaps in DNA via Exo1 activity (Giannattasio
et al., 2010). Second, we used mutants deficient in the nones-
sential DNA polymerase subunit Pol32 (Figure S2E), which,
when grown at low temperatures (14C), undergo faulty replica-
tion, leading to the accumulation of ssDNA gaps behind replica-
tion forks (Karras and Jentsch, 2010). Finally, ssDNA at telo-
meres can be exposed in mutants defective in the telomeric
ssDNA-binding protein Cdc13 (Garvik et al., 1995) (cdc13ts; Fig-
ure 2G). Because we observed HR protein SUMOylation (parallel
to checkpoint activation) under all these different conditions
(Figures 2F, 2G, and S2E), we conclude that, indeed, extended
ssDNA—not a DSB formation per se—is the crucial signal for
the SUMOylation wave.
Crosstalk between DNA Damage Response Pathways
Exo1 is phosphorylated at multiple sites by checkpoint kinases,
and this modification appears to inhibit its activity, thereby
limiting ssDNA accumulation and DNA damage checkpoint(B) Long-range resection by the action of Exo1 and Sgs1/Dna2, but not short-ra
DNA repair proteins. Similar to (A), but with MMS-treated cells lacking Sae2, Ex
contribute to induction of SUMOylation wave in DNA repair pathway.
(C) Short-range processing of DNA DSB ends by Sae2 andMre11 is not required fo
with MMS-treated Dmre11 Dsae2 cells expressing either WT or nuclease-dead (
(D) Nuclease activity of Exo1 is required for SUMOylation induction in response to
nuclease-dead (exo1-D173A, ND) Exo1.
(E) SUMOylation of repair proteins can be efficiently triggered by Exo1-resected
Zeocin-treated WT cells or cells lacking nonhomologous end-joining factor Yku7
(F) ssDNA gaps generated after UV light treatment by Exo1 in G1-arrested cells
cycling or G1-arrested WT or Exo1-deficient (Dexo1) cells, which were treated
checkpoint activation triggered by resection following DNA damage.
(G) Uncapping of telomeres and exposure of ssDNA in temperature-sensitive cd
cdc13ts cells that were grown to an OD600 of 0.7 at 24
C and then shifted to 37
See also Figure S2.activation (Morin et al., 2008). When we used a phosphoryla-
tion-defective exo1 mutant (exo1-SA), which is expected to
be irresponsive to checkpoint kinases, we observed that HR
protein SUMOylation upon MMS treatment was substantially
increased compared to wild-type (WT) cells (Figure S2F). This
suggests that inactivation of the checkpoint response may
lead to increased SUMOylation of HR proteins (as previously
observed for Rad52 [Ohuchi et al., 2009]) not only due to
increased DNA damage but perhaps also because Exo1-
dependent DNA resection is not repressed. Indeed, inactivation
of the checkpoint pathway by removing the genome integrity
checkpoint kinase Mec1 (Dmec1 and Dsml1; the used Dsml1
mutant suppresses the otherwise lethal phenotype of Dmec1)
or its adaptor protein Ddc2 (Dddc2 and Dsml1) pronouncedly
induced HR protein SUMOylation even in the absence of exog-
enous DNA damage (MMS; Figure S2G). Similarly, absence of
the checkpoint transducer Rad9 (Drad9) also strongly induced
the SUMOylation wave (Figure S2H). Lastly, mutants deficient
in subunits of the 9-1-1 checkpoint clamp (Drad17 or Dmec3)
triggered the response (Figure S2I). Notably, absence of check-
point signaling caused significant HR protein SUMOylation
even in the absence of long-range resection (Dexo1 and
Dsgs1) (Figure S2J), probably because ssDNA accumulates in
checkpoint mutants at collapsed replication forks. Further-
more, reagents like HU and 4NQO that barely induce HR
protein SUMOylation in WT cells strongly triggered the
SUMOylation wave if checkpoint signaling is defective (Fig-
ure S2K). We thus conclude that the SUMOylation wave
acts parallel to the checkpoint-signaling cascade; however,
checkpoint kinases keep ssDNA formation and hence the
SUMOylation trigger in check.
The SUMOylation Wave Is Catalyzed by the DNA-Bound
SUMO Ligase Siz2
We next asked how ssDNA might trigger HR protein SUMOyla-
tion mechanistically. We first speculated that perhaps the
responsible SUMO ligase might bind ssDNA specifically. By
analyzing single mutants of the genes of the three known
SUMO ligases of mitotic cells (Dsiz1,Dsiz2, andmms21-11 cata-
lytically inactive allele), we observed almost complete absence
of DNA damage-induced HR protein SUMOylation in cells defi-
cient in Siz2 (Figures 3A and S3A). As HR protein SUMOylation
was normal in the other two mutants, we conclude that Siz2,nge processing of DNA ends by Sae2 endonuclease, triggers SUMOylation of
o1, and Sgs1 or both Exo1 and Sgs1. Both branches of long-range resection
r the induction of SUMOylation wave following DNA damage. Similar to (A), but
mre11-H125N) Mre11.
DNA damage. Similar to (A), but withMMS-treated cells expressing eitherWT or
DNA DSB ends in cells arrested in G1. Similar to (A), but with G1-arrested and
0 (Dku70) or Yku70 and Exo1 (Dku70 and Dexo1).
are sufficient to trigger SUMOylation of repair proteins. Similar to (A), but with
either with MMS or UV light (80 J/m2). Hyperphosphorylated Rad53 indicates
c13ts mutants triggers HR protein SUMOylation. HisSUMO Ni PD from WT and
C.
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a SUMO-ligase of the conserved PIAS family, is the key enzyme
responsible for HR protein SUMOylation.
Siz2 indeed bindsDNA in vitro, however, only weakly to ssDNA
(Figure 3B). Furthermore, Siz2 has no discernable selectivity
toward structures resembling resected DNA or replication forks
(Figure S3B). Siz2 possesses an SP-RING domain required for
its ligase activity, a PINIT domain linked to substrate binding,
and an N-terminally located SAP domain, which mediates DNA
binding in other proteins (Palvimo, 2007; Yunus and Lima,
2009) (Figure S3C, scheme #1). This SAP domain is indeed
crucial as its deletion (Figure S3C, scheme #2) or replacement
of highly conserved residues of this domain by alanine (Siz2-
G64A,K66A,L69A; termed Siz2-SAP*; Figure S3C, scheme #3)
abolished DNA binding of the purified recombinant proteins
in vitro (Figure 3C). When Siz2-SAP* was expressed under
control of its endogenous promoter, the HR protein SUMOyla-
tion wave was severely reduced, but the enzyme was present
only at very low intracellular steady-state levels (Figure 3D).
Nonetheless, the mutant protein was not enzymatically inactive
as expression of this variant via a strong promoter (pCUP1-
SIZ2-SAP*) partially restoredMMS-induced HR protein SUMOy-
lation (Figures 3E and S3D). Notably, replacement of the SAP
domain by the sequence-specific DNA-binding domain of the
transcription factor Gal4 (Figure S3C, scheme #4) restored the
Siz2 protein level, yet without supporting HR protein SUMOyla-
tion (Figure S3E). In contrast, replacing the Siz2 SAP domain
by the SAP domain of the related enzyme Siz1 (Figure S3C,
scheme #5) not only led to a normal enzyme level in vivo but
also supported HR protein SUMOylation (Figure 3F). We thus
conclude that DNA damage-induced HR protein SUMOylation
requires SAP-domain-mediated localization of Siz2 on DNA;
however, Siz2 binds DNA broadly and not specifically ssDNA.
Because the PINIT domain of the Siz1 SUMO ligase appears to
contribute to substrate recognition (Yunus and Lima, 2009), we
also constructed a chimeric Siz2 variant in which we replaced
its PINIT domain by the analogous domain of the related enzyme
Siz1 (Figure S3C, scheme #6). However, this Siz2 variant sup-
ported HRprotein SUMOylation uponDNA damage (Figure S3F),
indicating that the two enzymes must differ in other aspects.
Indeed, a distinguishing feature of Siz2 is that it interacts specif-
ically with the Mre11 subunit of the MRX complex in two-hybridFigure 3. DNA Damage-Triggered SUMOylation Wave Is Catalyzed by
(A) SUMO ligase Siz2 stimulates HR protein SUMOylation after DNA damage. Den
from MMS-treated WT cells, mutants lacking SUMO ligases Siz1 (Dsiz1) or Siz2
(B) Recombinant HisSiz2 protein binds dsDNA and weaker ssDNA. Increasing amo
and ssDNA (20 fmol), and binding was detected by using chemiluminescent-bas
(C) Recombinant HisSiz2 variants either lacking the DNA-binding SAP domain (D
alanine residues (SAP*; #3 of Figure S3C) are unable to bind DNA. EMSA with 50
(D) DNA-binding-deficient Siz2 is destabilized in vivo and does not stimulate SU
expressing either Myc-tagged WT Siz2 or DNA-binding-deficient Siz2 (SAP*; #3
(E) Expression of DNA-binding-deficient Siz2 by the strong CUP1 promoter (CU
MMS treatment.
(F) Chimeric Siz2 carrying the N terminus of Siz1 harboring Siz1’s SAP domain (Si
functional in stimulating HR protein SUMOylation.
(G) SUMO-conjugating enzyme Ubc9 and SUMO ligase Siz2, but not Siz1, intera
sufficient for Mre11 interaction.
(H) A Siz2 variant Siz2DCterm with a deleted C-terminal tail (aa 416–726; #8 of F
See also Figure S3.assays (Figure 3G). Mre11 binding is mediated through the
C-terminal domain of Siz2, which harbors two SUMO-binding
motifs (Figures 3G and S3C). Deletion of the C-terminal SIM of
Siz2 (SIM2) or amino acid replacements within this motif (Fig-
ure S3C, scheme #7; V720A and V721A) not only abolished inter-
action with Mre11 (Figure S3G) but strongly affected HR protein
SUMOylation in vivo (Figure S3H). Because Mre11 also binds
Ubc9 in two-hybrid assays (Figure 3G), it seems plausible that
binding of Siz2 to Mre11 is achieved through Ubc9-catalyzed
SUMOylation of Mre11. Notably, binding of Siz2 to Mre11 is
crucial for the full HR protein SUMOylation wave response, but
not for HR protein SUMOylation per se, as a Siz2 variant lacking
its C-terminal tail (Figure S3C, scheme #8; aa 416–726, siz2D
Cterm) is still able to SUMOylate HR proteins, albeit weakly (Fig-
ure 3H). Furthermore, in the related enzyme Siz1, replacing
Siz1’s C-terminal tail with the C-terminal tail of Siz2 (Figure S3C,
scheme #9) does not create an enzyme capable of DNA
damage-induced SUMOylation of HR proteins (Figure S3I).
This indicates that the two enzymes not only differ in their tails
but differ in other aspects as well. Together, these data suggest
that the SAPdomain brings Siz2 onto chromatin generally, where
it can act on DNA-bound HR proteins, whereas the SIM-contain-
ing tail, uniquely present in Siz2, fixes and restricts the enzyme
on chromatin to SUMOylated Mre11 in order to promote the
full SUMOylation wave.
Artificial DNA Targeting of HR Proteins Is Sufficient
to Trigger Their SUMOylation
After we ruled out the possibility that the SUMOylation trigger
(ssDNA) operates through recruitment of the SUMO ligase
specifically to ssDNA, we considered an alternative model.
Because HR proteins are assembled on resected DNA, we
hypothesized that just recruitment of the HR proteins to DNA is
sufficient for their SUMOylation and that only DNA-bound HR
proteins are substrates for DNA-localized Siz2 SUMO ligase.
To test this idea, we artificially tethered HR proteins to DNA by
fusing them to the DNA-binding domain (aa 1–147, BD) of
the transcription factor Gal4. Indeed, a BD-Rad52 fusion
became efficiently SUMO modified, however, without causing
SUMOylation of the earlier-acting HR protein RPA (Rfa1) (Figures
4A, S4A, and S4B). Importantly, this SUMOylation reaction wasthe DNA-Bound SUMO Ligase Siz2
aturing Ni-NTA pull-down (Ni PD) was performed to isolate HisSUMOconjugates
(Dsiz2), or mms21-11 mutant cells.
unts of HisSiz2 were added to 50 end biotin-labeled 77-nucleotide-long dsDNA
ed electrophoretic mobility shift assay (EMSA).
SAP; #2 of Figure S3C) or having three highly conserved residues replaced by
end biotin-labeled 77-nucleotide-long dsDNA.
MOylation of HR proteins after DNA damage. HisSUMO Ni PD from Dsiz2 cells
of Figure S3C) following MMS treatment.
P1-SAP*) partially restores its protein level and HR protein SUMOylation after
z1 SAP; #5 of Figure S3C) is expressed to a similar level as WT Siz2 and is fully
ct with Mre11 in the two-hybrid system. C-terminal tail of Siz2 (aa 348–726) is
igure S3C) supports SUMOylation of HR proteins with reduced activity.
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Figure 4. Artificial DNA Targeting of HR
Proteins Is Sufficient to Trigger Their
SUMOylation
(A) N-terminal Gal4 DNA-binding domain (aa
1–147, BD) fusion protein BD-Rad52 ectopically
expressed from high-copy pGBD vector becomes
strongly SUMOylated in a Siz2-dependent manner
in the absence of DNA damage.
(B) Expression and subsequent SUMOylation of
BD-Rfa1 stimulates SUMO modification of both
endogenous RPA (Rfa1) and Rad52 in the absence
of DNA damage.
See also Figure S4.independent of DNA damage and bypassed the requirement of
ssDNA for the trigger. In contrast, when we used a BD-Rfa1
fusion, not only did Rfa1 become SUMOmodified in the absence
of DNA damage, but Rad52 did as well (Figure 4B). Notably,
SUMOylation of BD-Rad52 occurred on the same lysine residues
as for WT Rad52 and required Siz2 harboring its SAP domain
(Figures S4A and S4B). Together, these findings therefore
suggest that, indeed, DNA binding of the HR proteins is crucial
for triggering their Siz2-dependent SUMOylation. We hence
conclude that ssDNA operates as SUMOylation wave trigger
by bringing the substrates in vicinity to the DNA-bound SUMO
ligase.
Multisite SUMOylation of HR Proteins Promotes
Physical Interactions
In agreement with the above findings, we found that the SUMOy-
lated HR proteins are located on chromatin (Figure 5A). Because
the HR proteins not only function in the same pathway but also
physically interact, we next asked whether the SUMO modifica-
tions influence HR protein complex formation. Indeed, immuno-
precipitation of Rad59 after DNA damage coisolated proportion-
ally much more of the SUMOylated forms of RPA (Rfa1) and
Rad52 compared to the respective unmodified species (Fig-
ure 5B). Similarly, RPA (Rfa19Myc) immunoprecipitation brought
down with stronger preference the SUMOylated forms of
Rad52 (Figure S5A). Notably, this preference was further
increased when Rad51, the protein that is exchanged for RPA
by Rad52, is lacking (Figure S5A). In the absence of check-
point-mediated repression (Dmec1 and Dsml1), preferential
binding of RPA (Rfa29Myc) to SUMOylated Rad52 is already
significant without exogenous DNA damage but is strongly814 Cell 151, 807–820, November 9, 2012 ª2012 Elsevier Inc.further increased by DNA damage-
induced SUMOylation (Figure S5B).
Moreover, also in the absence of the
SUMO ligase Siz2, binding of RPA to
Rad52 was reduced (Figure S5B).
To address the in vivo relevance of
these modifications, we first aimed to
identify the target residues for SUMOyla-
tion. The strategy we used is based on
a mass spectrometric analysis of peptide
pools obtained after trypsin or thermoly-
sin digestion of purified SUMO conju-gates. Because these proteinases cleave SUMO (Smt3) close
to its C-terminal tail, we expected to get ‘‘branched’’ peptides
corresponding to HR-protein-derived fragments that had an
additional mass of the SUMO-derived fragment at acceptor
lysine (EQIGG in case of trypsin and IGG in case of thermolysin).
This approach identified two SUMOylation sites in Rfa1 and
identified one each in Rfa2, Rfa3, Rad59, and Rad52 (Figure 5C).
To confirm these sites, we mutated the corresponding genes in
the genome in order to replace the acceptor lysine residues by
arginine residues. Indeed, SUMOylation in vivo was either abol-
ished (Rfa2 and Rfa3) or strongly reduced (Figures 5D–5G), indi-
cating that our approach identified the major attachment sites.
Rfa1 and Rad59 possess additional minor SUMOylation sites
because the elimination of additional SUMOylation consensus
sites reduced modification of these proteins in vivo even further.
Notably, expression of a lysine-less SUMO variant (SUMO-KRall)
as the only source of SUMO resulted in the disappearance of the
di- and tri-SUMOylated species of Rfa2 and Rfa3 (Figures 5D
and 5E). Because this SUMO variant cannot form lysine-linked
poly-SUMO chains, Rfa2 and Rfa3 seem to be partially modified
by poly-SUMOylation. Thus, DNA damage-induced SUMOyla-
tion of HR proteins is excessive in that a whole set of repair
proteins undergoes multisite modification by SUMO and also
by poly-SUMO chains. Importantly, abolishing SUMOylation at
individual target sites did not negatively influence SUMOylation
at other sites or other proteins, indicating that SUMOylation
occurs independently and in parallel.
Because conjugated SUMO typically interacts with SIMs, we
next asked whether the HR proteins possess these motifs.
Indeed, bioinformatic searches predicted multiple SIMs in basi-
cally all repair factors (Table S1). When we probed peptides of
a length of 12 aa harboring these motifs flanked by their natural
sequences for binding to poly-SUMO chains in vitro, we found
that, indeed, a significant number had SUMO-binding properties
(Figure S5C). This indicates that the HR proteins are not only
excessively SUMOylated at multiple sites but are also decorated
with amino acid motifs that have SUMO-binding properties.
HR Protein SUMOylation Accelerates DNA Repair
Because mutants defective in SUMOylation of individual HR
proteins did not exhibit sensitivities toward DNA-damaging
agents (data not shown), we asked whether wholesale elimina-
tion of SUMOylation sites of multiple HR factors would affect
DSB repair. We constructed a mutant strain (termed KRmutant)
in which we changed at their endogenous genomic loci the
codons of 11 SUMOylation target lysine residues to arginine
codons of the core repair proteins RPA, Rad52, and Rad59
(rfa1-K133R,K170R,K427R rfa2-K199R rfa3-K46R rad52-
K10R,K11R,K220R rad59-K207R,K228R,K238R). The obtained
KR strain grew atWT rates (Figure 6A, left) and showed no sensi-
tivity to DNA-damaging agents in plating assays (data not
shown). However, when growth curves were measured, the KR
strain exhibited a substantial delay of roughly 4 hr upon chronic
exposure to MMS compared toWT cells (Figure 6A, right). More-
over, spontaneous and MMS-induced interchromosomal
recombination rates were reduced in this mutant (Figure 6B).
The finding that the KR mutant and the strain deficient in Siz2
(Dsiz2) have largely identical phenotypes and are epistatic
(Figures 6A and 6B) revealed that, in the tested DNA repair
pathway, Siz2 acts primarily via SUMOylation of HR proteins.
A crucial step in HR-mediated DSB repair is the loading of
Rad51 onto resected DSB ends, which is governed by the forma-
tion of the RPA-Rad52-Rad59 complex (Davis and Symington,
2003). Because Siz2-mediated SUMOylation fosters physical
interactions within this complex, we tested whether Siz2 affects
the loading of Rad51 to a single DSB created by HO endonu-
clease at the yeastmating type (MAT) locus (Figure 6C). Although
much less potent than MMS-induced DNA damage, a single
DSBwas sufficient to trigger the SUMOylation wave both in cells
lacking (donor deficient; Dhml Dhmr) or harboring homologous
donor sequences (HMLa) for repair (Figures S6A and S6B).
When we monitored by chromatin immunoprecipitation (ChIP)
the recruitment of repair factors to sites 0.2 kb and 5.7 kb distal
to the persistent DSB (donor-deficient strain), we found that RPA
(Rfa19Myc) was recruited rapidly and with similar kinetics in WT
and Dsiz2 cells (Figure 6C, right top). In contrast, loading of
Rad51 was delayed in the absence of HR protein SUMOylation
(Figure 6C, right bottom). Moreover, when we directly assayed
for repair of the HO-induced DSB at the MAT locus (mating
type switching), we found that repair was substantially delayed
in the KRmutant compared toWT (Figure 6D). We thus conclude
that the SUMOylation wave accelerates DSB repair by fostering
HR protein complex formation, which in turn stimulates the
loading of the recombinase Rad51 to the sites of repair.
DISCUSSION
Ever since its discovery 15 years ago, the SUMO modification
pathway remained enigmatic because of its unorthodoxfeatures. Particularly puzzling—especially by comparison to
the ubiquitin system—is the small set of enzymes responsible
for the modification of a large number of SUMO substrates.
This discrepancy, the lack of distinctive modification signals in
substrates equivalent to ligase-binding ‘‘degrons’’ in the ubiqui-
tin pathway, plus the apparent promiscuity of the SUMOylation
enzymes in vitro, have raised the question of how substrate
specificity is provided. Equally peculiar is the phenomenon that
SUMOylation affects most frequently only a very small fraction
of a given substrate and that cells expressing SUMOylation-
deficient mutant substrates often barely exhibit deleterious
phenotypes.
Protein Group Modification
By using SUMOylation of HR proteins as a case study, we
discovered that the SUMO pathway operates surprisingly
different from typical protein modification systems. Whereas
most PTMs are highly specific for selected individual proteins
in order to endow them with new functions or properties,
SUMOylation appears to frequently target a protein group rather
than an individual protein. In the case of the HR pathway,
multiple repair proteins are synchronously modified by a
SUMOylation wave. Strikingly, most HR proteins affected by
SUMOylation are modified at multiple sites, and these sites are
not conserved in homologs of other species. A similar scenario
is found for several other protein groups like proteins involved
in nucleotide excision repair (Figure 1B; Silver et al., 2011), yeast
septins (Johnson and Blobel, 1999; Johnson and Gupta, 2001;
Takahashi et al., 2001), ribosomal proteins (Finkbeiner et al.,
2011a, 2011b; Panse et al., 2006), and proteins of snoRNPs
(Westman and Lamond, 2011). In all these cases, the SUMOyla-
tionmachinery seems to target several proteins of the respective
complexes synchronously and often at multiple sites. From
these findings, we thus assume that ‘‘protein group modifica-
tion’’ is a typical feature of the SUMO pathway. Notable known
exceptions from this rule are SUMOylation of RanGAP (Werner
et al., 2012)—as the protein is itself a SUMO ligase—and
PCNA. Indeed, PCNA SUMOylation (catalyzed by Siz1) is highly
special as SUMOylation targets the same conserved acceptor
site in PCNA (K164) as ubiquitylation (to conduct different repair
pathways) (Hoege et al., 2002). Notably, protein group modifica-
tion in the SUMO pathway also differs substantially from other
PTM waves like phosphorylation reactions, as most of the
SUMO modifications are functionally additive or redundant and
do not proceed by a reaction cascade.
SUMOylation Specificity
Protein group modification requires different rules for substrate
specificity. Whereas selective modification of an individual
substrate involves a highly specific interaction between a modi-
fying enzyme and its substrate, protein group modification may
only require close proximity of a promiscuous enzyme to its
multiple substrates, plus suitable modification sites, probably
within flexible protein domains. Indeed, SUMOylation sites are
frequently not conserved and hence are outside of conserved
functional domains. Specificity toward a protein group is
provided by two principles: a highly specific trigger and topolog-
ical specificity. As detailed above, the specific SUMOylationCell 151, 807–820, November 9, 2012 ª2012 Elsevier Inc. 815
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trigger for HR proteins is the formation of ssDNA, which serves
as a binding platform for the substrates. As we have shown for
Rfa1 and Rad52, artificial DNA targeting is sufficient to trigger
their SUMOylation (Figure 4) as Siz2 is already on chromatin
due to its SAP domain. Thus, topological specificity is provided
by locally concentrated substrates (on ssDNA) and a highly local-
ized SUMO ligase. Whereas protein group modification of sep-
tins involves localized Siz1 (Johnson and Gupta, 2001; Reindle
et al., 2006), HR protein modification requires Siz2 of the same
protein family. Overall, Siz1 and Siz2 have similar domain orga-
nizations and DNA-binding properties; however, they differ in
Siz2’s ability to selectively bind Mre11 of the MRX complex.
Because specificity is provided by these two basic principles,
there is no need for a large set of different ligases in the SUMO
pathway. Importantly, protein group modification also solves
the puzzle of why usually only a very small fraction of a given
substrate is SUMO modified. In the case of HR proteins, this
small fraction apparently represents the DNA-bound population
engaged in repair and that is at reach of the Mre11-associated
and DNA-bound SUMO ligase.
SUMO as a Protein Glue
Our systematic analysis of SUMOylation sites of HR proteins re-
vealed that individual SUMO modifications act synergistically,
which explains why single acceptor site mutants usually exhibit
barely any deleterious phenotype. Because SUMOylation of
HR proteins fosters protein-protein interactions, the most logical
explanation for the observed functional synergy is that individual
SUMO-SIM interactions add up affinities for complex formation.
Three important features appear to be crucially relevant for this
activity: the proteins in question possess low affinities toward
their neighbors on their own, even in the absence of SUMOyla-
tion; they are modified at multiple sites; and they are decorated
with multiple SIMs. Because SIMs are very short sequence
motifs, our finding that basically all HR proteins possess multiple
in vitro functional SIMs may not be surprising. However, it
suggests that they represent widely scattered latent ‘‘adhesive
surfaces’’ for potential SUMO interactions. We thus like to
propose that SUMO functions comparable to a glue. In this
model, upon a specific signal, a DNA-bound, concentrated
SUMO ligase catalyzes a local ‘‘SUMO spray’’ on nearbyFigure 5. Multisite SUMOylation of HR Proteins on Chromatin after
Formation
(A) SUMOylated HR proteins are enriched in chromatin after DNA damag
overexpressing HisSUMO into soluble (SOL) and chromatin-enriched (CHR) frac
formed. SUMOylated forms of Rfa1 and Rad52 were specifically enriched in the
histone H3 lysine-4 trimethylation and the ER membrane protein Dpm1 were det
(B) SUMOylation fosters interaction between HR proteins and promotes comple
induced DNA damage, were coimmunoprecipitated (co-IP) from extracts by
SUMOylated species is reflected by the ratios of SUMO-modified/unmodified HR
(C) Identification of SUMO attachment sites in HR proteins by using proteomic
damage, HisSUMO conjugates were digested either with trypsin or thermolysin, a
lysines were detected by LC-MS/MS.
(D–G) HR proteins are SUMOylated independently at multiple sites following DN
C-terminally HA-tagged Rfa3 (E), Rfa1 (F), C-terminally HA-tagged Rad59 (G), or t
in which all lysine residues were replaced by arginines (HisSUMO-KRall) as the on
from multisite SUMOylation (D and E).
See also Figure S5 and Table S1.proteins, thereby potentiating physical interactions and in that
way accelerating overall repair. Because the SUMO ligases are
enzymatically largely promiscuous, they predictably also modify
sites that do not contribute to complex stabilization. In other
words, although SUMO modifications (e.g., in the HR pathway)
act synergistically and add up for repair, not all modifications
are expected to be equally important. Furthermore, superfluous
SUMO modifications, not protected by interaction with a SIM-
containing partner, might be rapidly removed by de-SUMOyla-
tion enzymes (Geiss-Friedlander and Melchior, 2007). Because
many biological pathways take place within ‘‘nuclear bodies’’
or ‘‘foci,’’ it seems attractive to speculate that several of these
large protein assemblies are stabilized by the mechanism we
describe here. An interesting remaining question is how the
SUMO-bridged complexes become disassembled once their
activities are no longer needed. Attractive possibilities are that
disassembly might be promoted by regulated de-SUMOylation,
by proteolytic removal involving SUMO-targeted ubiquitin
ligases (STUbLs; Galanty et al., 2012; Prudden et al., 2007; Yin
et al., 2012), or perhaps by the activities of ‘‘segregases’’ such
as Cdc48/p97 of the ubiquitin pathway (Dantuma and Hoppe,
2012; Jentsch and Rumpf, 2007).
EXPERIMENTAL PROCEDURES
Yeast Strains
Yeast (S. cerevisiae) strains used in this study are listed in Table S2.
Biochemical and Molecular Biology Techniques
The biochemical andmolecular biology techniques used in this study are stan-
dard procedures. Detailed descriptions for individual methods are provided in
Extended Experimental Procedures.
SILAC Mass Spectrometry
For the detection of SUMO conjugates enriched upon MMS and UV light treat-
ment (Figures 1A and 1B), SILAC was used. Yeast cells deficient in biosyn-
thesis of lysine and arginine (Dlys1and Darg4) expressing His-tagged SUMO
(HisSUMO) were grown for at least ten divisions in synthetic complete (SC)
media supplemented either with unlabeled (Lys0 and Arg0; light) or heavy-
isotope-labeled amino acids (Lys8 and Arg10; heavy) from Cambridge Isotope
Laboratories. Exponentially dividing cells grown in heavy media were treated
with 0.2% MMS for 90 min, harvested, and combined with equal amount of
untreated cells grown in light media. Alternatively, cells grown in heavy mediaDNA Damage Fosters Physical Interaction and Promotes Complex
e. Following subcellular fractionation of MMS-treated WT cells or cells
tions, denaturing Ni-NTA pull-down (Ni PD) of HisSUMO conjugates was per-
chromatin fraction. To control chromatin fractionation efficiency, the levels of
ected in fractions prior to Ni PD.
x formation. RPA-Rad52-Rad59 complexes, which assemble following MMS-
immunoprecipitation of C-terminally HA-tagged Rad59. The preference for
protein fractions in co-IPs versus inputs (quantified by ImageJ software).
mass spectrometry. Following Ni-NTA pull-down after MMS-induced DNA
nd branched peptides with characteristic SUMO remnants attached to target
A damage. HisSUMO Ni PD from MMS-treated cells expressing WT Rfa2 (D),
heir various KRmutant variants. In addition, cells expressing a HisSUMO variant
ly source of SUMO were used for pull-down to distinguish poly-SUMOylation
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were UV irradiated (80 J/m2) instead of MMS treatment. Then, HisSUMO conju-
gates were isolated by using denaturing Ni-NTA pull-down and separated on
4%–12% Bis-Tris gel. The whole lane was excised in ten slices and proteins
were digested with trypsin and analyzed by LC-MS/MS.
Detection of SUMOylation Sites
For the detection of SUMOylation sites, proteins were digested with trypsin
(Shevchenko et al., 1996) or thermolysin. Extracted peptides were analyzed
by Orbitrap mass spectrometry (Olsen et al., 2005) and identified by using
MaxQuant software (Cox and Mann, 2008). The data set was searched for
peptides harboring extra masses on lysines (branched peptides) correspond-
ing to proteolytic remnants of the C-terminal tail of SUMO. In the case of
trypsin digestion, extra masses corresponding to a SUMO remnant with the
sequence EQIGG were expected, and in the case of thermolysin digestion,
with the sequence IGG.
Detection of SUMO-Interacting Motifs
For the detection of SIMs, 12-mer peptides corresponding to in-silico-pre-
dicted SIMs and flanking sequences were synthesized by a MultiPep instru-
ment (INTAVIS Bioanalytical Instruments AG) on a membrane, incubated
with poly-SUMO-3 chains (UCL-310; BostonBiochem), and probed analogous
to western blotting with antibodies directed against SUMO-2/3. For details,
see Extended Experimental Procedures (Peptide Array Immunoblotting).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and two tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.10.021.
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(A) Cells deficient in HR protein SUMOylation either due to the absence of Siz2 (Ds
and Rad59 (KR) show delayed growth upon chronic exposure to DNA damage. G
cells deficient in SUMOylation sites of HR proteins (KR) and also in combination
0.02% MMS.
(B) Deficiency in HR protein SUMOylation results in reduction of spontaneous a
between chromosomal his1 heteroalleles were measured by fluctuation analysis i
sites of HR proteins (KR). The results are the average of at least three independe
(C) Rad51 loading at the DSB is affected in the absence of Siz2. A single unrepai
HMR (donor-deficient strain). DSB induction was monitored in WT and Siz2-defici
HO cut site. ChIP directed against Rad51 and C-terminally Myc-tagged Rfa1 at 0.
compare loading of RPA and Rad51 in the absence of HR protein SUMOylation. T
represent SEM.
(D) The speed of DSB repair is slowed down inmutants deficient in SUMOylation o
repair reaction) was transiently induced by HO at MATa in WT cells, cells lacking
Rad52 protein (Drad52), and the KR mutant. Repair kinetics was measured by re
repaired product Ya atMAT, 1, 2, and 3 hr after inactivation of HO (shift from galac
independent studies, and error bars represent SEM.
See also Figure S6.REFERENCES
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